Search research articles
Contact Us
Filters
Showing results (41-50 of 255) with videos related to
Page
of 26
Sort By:
Audiology & Neuro-Otology
|
May 1, 2015
Neuromagnetic cortical activation during initiation of optokinetic nystagmus: an MEG pilot study
Paulus S Rommer, Roland Beisteiner, Kirsten Elwischger, et al.
Current Pharmaceutical Design
|
July 5, 2021
Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Anja Steinmaurer, Isabella Wimmer, Thomas Berger, et al.
The New England Journal of Medicine
|
April 14, 1983
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon
R J Rodeheffer, J A Rommer, F Wigley, et al.
Frontiers in Immunology
|
March 3, 2020
Editorial: Multiple Sclerosis - From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
Paulus S Rommer, Martin S Weber, Zsolt Illes, et al.
Biomedicines
|
November 11, 2022
Immunosenescence in Neurological Diseases-Is There Enough Evidence?
Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Journal of Neurology
|
May 18, 2021
Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
Tobias Zrzavy, Anna Pfitzner, Peter Flachenecker, et al.
Clinical and Translational Medicine
|
February 22, 2024
Ineffective control of Epstein-Barr virus infection is seen in MS: What is next?
Paulus Rommer, Elisabeth Puchhammer-Stöckl, Hans Lassmann, et al.
CNS Drugs
|
June 25, 2011
Rituximab for secondary progressive multiple sclerosis: a case series
Paulus S Rommer, Robert Patejdl, Alexander Winkelmann, et al.
Expert Review of Clinical Immunology
|
January 11, 2018
Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge
Uwe Klaus Zettl, Michael Hecker, Orhan Aktas, et al.
Journal of Neurology
|
March 21, 2009
Monoclonal antibodies in the therapy of multiple sclerosis: an overview
P S Rommer, O Stüve, R Goertsches, et al.
Page
of 26
Search research articles
Search
Showing results (41-50 of 255) with videos related to
Sort By:
Page
of 26
Audiology & Neuro-Otology
|
May 1, 2015
Neuromagnetic cortical activation during initiation of optokinetic nystagmus: an MEG pilot study
Paulus S Rommer, Roland Beisteiner, Kirsten Elwischger, et al.
Current Pharmaceutical Design
|
July 5, 2021
Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Anja Steinmaurer, Isabella Wimmer, Thomas Berger, et al.
The New England Journal of Medicine
|
April 14, 1983
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon
R J Rodeheffer, J A Rommer, F Wigley, et al.
Frontiers in Immunology
|
March 3, 2020
Editorial: Multiple Sclerosis - From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
Paulus S Rommer, Martin S Weber, Zsolt Illes, et al.
Biomedicines
|
November 11, 2022
Immunosenescence in Neurological Diseases-Is There Enough Evidence?
Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Journal of Neurology
|
May 18, 2021
Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
Tobias Zrzavy, Anna Pfitzner, Peter Flachenecker, et al.
Clinical and Translational Medicine
|
February 22, 2024
Ineffective control of Epstein-Barr virus infection is seen in MS: What is next?
Paulus Rommer, Elisabeth Puchhammer-Stöckl, Hans Lassmann, et al.
CNS Drugs
|
June 25, 2011
Rituximab for secondary progressive multiple sclerosis: a case series
Paulus S Rommer, Robert Patejdl, Alexander Winkelmann, et al.
Expert Review of Clinical Immunology
|
January 11, 2018
Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge
Uwe Klaus Zettl, Michael Hecker, Orhan Aktas, et al.
Journal of Neurology
|
March 21, 2009
Monoclonal antibodies in the therapy of multiple sclerosis: an overview
P S Rommer, O Stüve, R Goertsches, et al.
Page
of 26